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The PAT family of lipid storage droplet proteins comprised five members, each of which has become an estab-
lished regulator of cellular neutral lipid metabolism. Perilipin 5 (also known as lsdp-5, MLDP, PAT-1, and
OXPAT), the most recently discovered member of the family, has been shown to localize to two distinct
intracellular pools: the lipid storage droplet (LD), and a poorly characterized cytosolic fraction. We have
characterized the denser of these intracellular pools and find that a population of perilipin 5 not associated
with large LDs resides in complexes with a discrete density (~1.15 g/ml) and size (~575 kDa). Using immu-
nofluorescence, western blotting of isolated sucrose density fractions, native gradient gel electrophoresis, and
co-immunoprecipitation, we have shown that these small (~15 nm), perilipin 5-encoated structures do
not contain the PAT protein perilipin 2 (ADRP), but do contain perilipin 3 and several other as of yet unchar-
acterized proteins. The size and density of these particles as well as their susceptibility to degradation by
lipases suggest that like larger LDs, they have a neutral lipid rich core. When treated with oleic acid to pro-
mote neutral lipid deposition, cells ectopically expressing perilipin 5 experienced a reorganization of LDs in
the cell, resulting in fewer, larger droplets at the expense of smaller ones. Collectively, these data demon-
strate that a portion of cytosolic perilipin 5 resides in high density lipid droplet complexes that participate
in cellular neutral lipid accumulation.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Nearly all cells possess the ability to store neutral lipid, but when
excessive this storage is not without consequence. As the obesity
epidemic spreads in Western society, a corresponding increase is ob-
served in type II diabetes mellitus (T2DM) [1]. While not exclusively
causal, ectopic neutral lipid storage in liver and muscle is emerging
as key factors in the etiology of these diseases [2]. Several recent
studies have made mechanistic advances into the cause of insulin
resistance as it relates to altered neutral lipid storage. Bostrom et al.
have shown that sequestration of pro-fusogenic proteins of the
SNAP/SNARE pathway becomes localized on LDs preventing their
use in fusion of GLUT4 coated vesicles with the plasma membrane,
decreasing cellular insulin sensitivity [3,4]. Others have shown that
overabundant neutral lipid storage in liver blunts signaling responses
(AKT) important in the insulin response and may likely contribute to
the development of T2DM [5].
At the core of these pathologies is the cell's ability to sequester
neutral lipid. The PAT family consists of five related genes which
give rise to at least seven different proteins (perilipin A, B, and C,
ADRP [also called Adipophilin or ADFP], TIP47, OXPAT [also called
MLDP, perilipin 5, PAT-1, or LSDP5] and s3-12). This family has
recently undergone a revision in nomenclature, such that now the
proteins are all known as perilipins (to reflect their binding to the
periphery of lipid droplets) and numbered in their order of discovery
(perilipin, ADRP, TIP-47, s3-12, and OXPAT, respectively) [6]. Some
combination of these proteins coats the surface of all LDs. The protein
family members can be divided into those proteins solely found on
the surface of the lipid storage droplet (perilipins 1 and 2; the
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constitutive or c-PATs) and those that are found on both the lipid
storage droplet and the cytosol (perilipins 3, 4, and 5; the exchange-
able or e-PATs) [7]. For reviews, please see [8–14].
PAT proteins have been shown to act as cofactors for lipases
(perilipin 1A with HSL or ATGL), as binding partners for other pro-
teins (perilipin 1A with CGI-58/abhd-5, a coactivator of ATGL and
lyso-PA acyltransferase) [15–21] and as interaction partners with
trafficking proteins (perilipin 3 with M6PR and Rab 9, and perilipin
2 with SNAP-23, syntaxin 5, and Vamp 4) [3,4,22–24]. In general,
PAT proteins appear to coat LDs in a hierarchical fashion as LDs
mature, with perilipin 4 found on the most nascent droplets close
to the plasma membrane, followed by perilipin 3, and then perilipin
2 or perilipin 1 found on the most mature LDs [20,25–28]. It is not
totally clear where perilipin 5 exists in this hierarchy, although it
does not appear to displace perilipin 2 from the droplet surface.
Initial studies on perilipin 5 revealed that the gene is expressed
in tissues with high capacity for fatty acid oxidation (such as brown
adipose tissue, liver, heart, and skeletal muscle) and regulated by
PPAR-α [29–31]. Subsequent studies have shown that perilipin 5
also interacts with CGI-58 and HSL [20,32]. All of these studies have
focused on the roles perilipin 5 play on the lipid storage droplet,
although it is exchangeable and may be found on other structures
(cytosol or endoplasmic reticulum) as well [33].
In the current work, we present novel evidence suggesting that
the cytosolic pool of perilipin 5 is not found free in solution, but
rather is bound to structures of discrete density. Furthermore, we
have characterized this pool of perilipin 5, and found that it consists,
at least partially, of discrete structures of small size (b20 nm in
diameter) with biochemical characteristics reminiscent of circulating
high density lipoprotein particles. We propose that these high density
lipid droplets (HDLDs) may represent nascent intracellular sites for
lipid accumulation. Upon treatment of cells with oleic acid to promote
neutral lipid storage, perilipin 5 was found to shift from this cytosolic
HDLD pool to more buoyant LDs. We propose that these two distinct
pools play key roles in lipid storage and mobilization mediated by
perilipin 5.
2. Methods
2.1. Reagents
Unless otherwise noted, all chemical reagents were purchased
from Sigma (St. Louis, MO) or Fisher Chemical, and all culture media
were obtained fromGibco/Invitrogen. Rabbit polyclonal serum against
perilipin 2 and the perilipin-GFP cDNA construct were gifts from Dr. C.
Londos (National Institutes of Health). Mouse monoclonal anti-FLAG
(M2), anti-FLAG M2 affinity agarose gel, FLAG eluting peptide, and
the GPO-Trinder triglyceride kit were purchased from Sigma. Mouse
monoclonal anti-perilipin 2 and guinea pig polyclonal anti-perilipin
3 antibodies were obtained from Research Diagnostics. Rabbit poly-
clonal anti-perilipin 3 antibodies were purchased from Novex. Rabbit
anti-calreticulin antibody was purchased from BD Biosciences.
Mouse monoclonal antibody against mitochondrial complex IV was
purchased from MitoSciences. Rabbit polyclonal anti-FLAG was pur-
chased from Cell Signaling Technology or Sigma. Murine CHO-K1
cells were obtained from the American Type Culture Collection.
BODIPY 558/568 C12, ProLong Gold Antifade mounting kits, PS-Speck
microscope point source kit, and Alexa Fluor-conjugated secondary
antibodies used for immunofluorescence were obtained from Mo-
lecular Probes/Invitrogen. Precast Novex Tris–glycine acrylamide
gels, Novex Bis–Tris gradient polyacrylamide gels, NativePAGE sample
preparation kit, NativeMark protein molecular weight standards, and
NativePAGE running buffer kit were obtained from Invitrogen. The
highmolecularweight native proteinmarker kit used in native gradient
gel electrophoresis was purchased from GE Healthcare, as was the pro-
tein silver staining kit. Anti-mouse and anti-rabbit TrueBlot horseradish
peroxidase (HRP)-conjugated secondary antibodies (raised against the
native forms of IgG molecules) were obtained from eBioscience,
and were used in the detection of primary antibodies when probing
immunoblots of immunoprecipitated material; all other HRP-
conjugated secondary antibodies used in immunoblotting were pur-
chased from Pierce Biotechnology. SuperSignal chemiluminescent
substrate and the BCA protein assay kit were also obtained from
Pierce Biotechnology. Oleic acid was obtained from EMD Chemi-
cals/Calbiochem. Formvar-carbon coated 300 mesh copper grids
were from Ted Pella. Rabbit anti-mouse perilipin 5 polyclonal
antisera were generated by Invitrogen against the peptide NH3+-
PGSSLGELDQQNVVNRC-COO−. This peptide corresponds to a region
of the amino terminus of perilipin 5 from Mus musculus which has a
minimal overlap with other PAT family members. No crossreactivity
was found with either perilipin 2 or 3 (perilipins 1 and 4 have not
been tested but are not expressed in the cell lines employed in
these studies). The specificity of the antisera was checked against
3xFLAG-tagged perilipin 5 and an anti-perilipin 5 antibody gra-
ciously provided by Dr. Perry Bickel (UT Health Science Center,
Houston, Texas).
2.2. Generation of perilipin 5-3x-FLAG fusion protein and derivatives
The polymerase chain reaction was used to introduce a novel
BglII site as well as delete the stop codon found in the cDNA coding
for murine perilipin 5. This facilitated the in-frame cloning of the
c-DNA into the expression vector. The T7 primer was used in the
forward direction and the sequence of the mutagenic reverse primer
was 5′-GATAGTCAGATCTCCCAGCTCTGGCATC-3′. This PCR product
was cloned into a pGEM T-Vector, cut with BglII and EcoRI, and
subsequently cloned into the 3x-FLAG expression vector between
the BglII and EcoRI sites. To remove the FLAG epitopes, the perilipin
5-3x-FLAG plasmid was cut with BglII, filled in with Klenow frag-
ment to generate a stop codon, and a blunt ended ligation was
performed to recircularize the plasmid. Transfection grade plasmid
DNA was obtained using a Qiagen endo-free maxiprep kit. The iden-
tity of the perilipin 5 cDNA was confirmed by sequencing of the
complete coding sequence.
2.3. Cell culture and expression of perilipin 5 in CHO cells
CHO-K1 cells weremaintained in Ham's F-12medium (Invitrogen)
containing 5% Cosmic Calf Serum (HyClone), 10 mM L-glutamine,
14 mM NaHCO3, 100 units/ml penicillin, and 100 units/ml streptomy-
cin at 37 °C in a 5% CO2 atmosphere. Functional studies of perilipin 5
were performed using CHO-K1 cells stably overexpressing epitope-
taggedmurine perilipin 5, transfected according to the LipofectAMINE
protocol (Invitrogen). Where indicated, some CHO cells were trans-
fected with the perilipin 5 expression vector in which the FLAG
epitopes were removed. In control experiments, CHO cells were trans-
fected with the 3x-FLAG expression vector in the absence of perilipin
5 cDNA. Selection was performed using 300 μg/ml G418. For lipid
loading experiments, cells were either treated for 24 h with fresh
medium or medium supplemented with 400 μM oleic acid complexed
to fatty acid-free bovine serum albumin (lipid loading media) to
promote the storage of triacylglycerols (TAGs).
2.4. Animal studies
8–10 week old male C57Bl6J mice from The Jackson Labs were
housed on a 12-hour light/dark cycle and provided food and water
ad libitum. The afternoon prior to the experiment food was removed
and animals were fasted until 10 AM the next morning to elevate
hepatic perilipin 5 expression [29–31]. All animal experimentation
was conducted in accordance with the guidelines of the Animal Care
and Use Committee of Otterbein College (protocol #2010-03-01-01).
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At the time of the experiment, animals were euthanized by exsan-
guination; livers and hearts were removed, rinsed in PBS, and minced
in the same buffer. Larger chunks of tissue were removed by a low
speed centrifugation (100 ×g, 30 s), and cells in the resulting super-
natant were allowed to swell in hypotonic lysis buffer (HLB; 10 mM
TRIS, pH 7.4, 1 mM EDTA,) on ice for 20 min prior to shearing through
a 28 g needle five passes. This suspension was centrifuged for 15 min
at 15,000 ×g to produce a post nuclear supernatant (PNS) used in
subsequent analysis.
2.5. Immunofluorescence microscopy, imaging and neutral lipid staining
Immunofluorescence microscopy was conducted as previously
described with modifications [25,34]. Cells were cultured on sterilized
glass coverslips, and neutral lipids were visualized by supplementing
lipid loading media or fresh basal growth media with 6 μM BODIPY
558/568 C12 for 24 h. Cells were then fixed with 4% paraformaldehyde
in PBS for 1 h and washed three times with PBS before mounting with
Prolong Gold for visualization.
In immunolabeling experiments, fixed cellsweremade permeable by
incubation with 0.2% Triton X-100 in PBS for 15 min at room tempera-
ture, and blocked with 1% non-fat dry milk/5% normal goat serum in
PBS for 1 h. For antigen detection, the following primary antibodies
were employed: rabbit polyclonal anti-FLAG (1:100), rabbit polyclonal
anti-perilipin 2 serum (1:500), mouse monoclonal anti-FLAG (1:200),
mouse monoclonal anti-perilipin 2 (1:5), rabbit anti-perilipin 3 (1:500)
and rabbit polyclonal anti-perilipin 5 (1:1000).
After washing three times with PBS containing 0.01% Triton X-100,
cells were incubated with secondary Alexa Fluor 488-conjugated goat
anti rabbit antibody (1:100). All antibodieswere diluted in PBS containing
2% goat serum with 0.01% Triton X-100. Following three additional
washeswithPBS containing0.01% TritonX-100, coverslipsweremounted
using ProLong Gold (Molecular Probes). For double labeling, primary an-
tibodies raised in different species were used simultaneously. Cells were
then incubated with species-specific secondary antibodies bearing differ-
ent fluorophores (all at 1:200 and prepared as described above). Cells
were visualized using a Zeiss 510 laser scanning confocal microscope
(Carl Zeiss Inc).
2.6. Lipid droplet morphometry
Cells cultured on glass coverslips were incubated for 24 h in lipid
loading media supplemented with 6 μM BODIPY 558/568 C12 to
label neutral lipids, then fixed and stained as described above. Nuclei
were counterstained with 5 μg/ml 4′,6-diamidino-2-phenylindole
(DAPI, Sigma). Specimens were then mounted and viewed using a
Nikon Eclipse TE200 inverted epifluorescence microscope (Nikon
Instruments). Single channel grayscale images (15–25 randomly se-
lected optical fields per treatment condition) were collected using a
SPOT RT camera and SPOT 4.0.5 imaging software (Diagnostic Instru-
ments). Prior to analysis, the pixels on the digital images were
inverted, such that the BODIPY-stained LDs appeared dark against a
white background to facilitate LD analysis. LD morphometric analysis
was performed using two methods. To address whether perilipin
5-3X-FLAG expression altered maximal LD size, the diameter of
the largest LD per cell was evaluated using SPOT imaging software
(method 1). Cells were classified based on the presence or absence of
perilipin 5-3X-FLAG expression as determined by anti-FLAG staining.
This method was insufficient, however, to allow precise measure-
ments of the numerous, smaller lipid droplets present in each cell.
For a more comprehensive analysis, the images were re-analyzed
using BioPix Tissue 1.5 software (BioPix Software) in which the
size and number of lipid droplets were evaluated by manual pixel
counting (method 2) [35]. For all size determinations, only in-
focus objects were evaluated; these were classified into size
categories based on diameter. Over 100 randomly selected cells
per condition were analyzed in each instance.
2.7. Subcellular fractionation
Cells were fractionated based on Weller and Yamaguchi protocols
[36,37] with the following modifications. Briefly, following overnight
treatments specified in each experiment, cells were rinsed in ice-cold
PBS, harvested by scraping, and collected by low-speed centrifugation.
The cell pellets (~120×106 cells/pellet) were resuspended in hypotonic
lysis buffer (HLB) supplemented with protease inhibitor cocktail
(Sigma) and the pelletswere allowed to swell on ice for 20 min. Homog-
enization was achieved using 5 passages though a 28-gage needle, and
the homogenates were subjected to centrifugation at 15,000 ×g for
15 min/4 °C to obtain a postnuclear supernatant (PNS). The PNS was
adjusted to 30% sucrose. For each homogenate, a discontinuous
sucrose gradient was prepared in HLB using one of two protocols. In
pilot experiments, conventional gradients (0–30% sucrose) comprised
the following (from bottom to top): weighted PNS (30% sucrose,
adjusted to 5 ml), 20% sucrose (2.5 ml), 10% sucrose (2.5 ml), and HLB
(1ml). In subsequent experiments, an extended sucrose gradient
(0–60% sucrose) was used consisting of: 60% sucrose (2 ml), 40%
sucrose (2 ml), weighted PNS (30% sucrose, 2 ml), 20% sucrose (2 ml),
10% sucrose (2 ml), and HLB (1 ml). Gradients were subjected to
centrifugation at 100,000 ×g for 16 h/4 °C (SW28.1 Ti swinging bucket
rotor, Beckman Coulter). Following centrifugation, either six or eleven
(as indicated in the text and figures) equal-volume fractions were col-
lected from the top. Aliquots from each fraction were then
subjected to dot blotting or separated either by SDS-PAGE, or NDGGE,
and transferred electrophoretically to nitrocellulosemembranes. Immu-
noblots were probed as described in the text and figure legends.
2.8. Immunoprecipitation
CHO-K1 cells expressing perilipin 5-3x-FLAGwere rinsed in ice-cold
PBS and collected into HLB, and a PNSwas prepared as described above.
The PNS (from approximately 2×107 cells in a 1 ml volume)was added
to 40 μl of thewashed anti-FLAGM2 affinity gel resin (prepared as indi-
cated in the accompanying literature) and incubated overnight on a ro-
tary mixer. The resin was recovered by brief centrifugation (5000 ×g
for 30 s) and washed 3 times in Tris-buffered saline (TBS; 150 mM
NaCl, 10 mM Tris–HCl, pH 7.2). The immunoprecipiated material was
eluted from the affinity resin using 100 μl of 1 mg/ml FLAG peptide.
2.9. Protein electrophoresis and immunoblot analysis
For SDS-PAGE, cells were harvested as described above, and gel elec-
trophoresis using Novex Tris–glycine 10% acrylamide gels (Invitrogen)
was performed to resolve 25 μg of total protein per lane. For non-
denaturing gradient gel electrophoresis (NDGGE), proteins were
resolved at 150 V for 2 h using Novex 3–12% Bis–Tris gradient gels
(Invitrogen) and components of the NativePAGE gel system, according
to the instructions of the manufacturer (Invitrogen). Proteins resolved
under either native or denaturing conditions were subsequently either
transferred electrophoretically to nitrocellulose membranes or sub-
jected to silver staining using a kit, according to the instructions of
the manufacturer (GE Healthcare). Alternately, protein dot blots were
prepared using the BioRadBioDot apparatus according to the manufac-
turer's instructions.
For immunoblotting, membranes were blocked for 1 h using 5%
nonfat dry milk in Tris buffered saline/Tween 20 (TBST) (150 mM
NaCl, 10 mM Tris–HCl pH 7.2, 0.1% Tween 20) prior to incubation
with primary antibodies (1 h at 25 °C or overnight at 4 °C). The
following primary antibodies were used: mouse anti-FLAG (1:1000),
rabbit anti-ADRP (1:2000), and guinea pig anti-TIP47 (1:2000).
After washing, the membranes were exposed to horseradish
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peroxidase-conjugated secondary antibodies and detected using
SuperSignal chemiluminescent substrate (Pierce) and the VersaDoc
Imaging System (Bio-Rad).
2.10. Transmission electron microscopy (TEM)
Electron microscopy was performed as previously described [38].
Briefly, a drop of sample was placed on a 300-mesh formvar-carbon
coated copper grid (Ted Palla) for 1 min and the excess fluid was
wicked away using a laboratory cleaning tissue. For negative staining,
a drop of 0.2% phosphotungstic acid (PTA) was then applied to the
grid for 30 s and subsequently drawn off from the edge of the grid
with filter paper. The specimens were allowed to air-dry prior to
observation using a Tecnai G2 Spirit electron microscope (FEI) oper-
ated at 80 kV.
2.11. Quantification of total cellular triacylglycerols
Cellswere grown to confluence in 100 mmculture dishes. Following
two washes with cold PBS, cells were collected in 500 μl cold PBS and
then sonicated for 10 s at a 2.0 power setting on aMisonix 3000 Sonica-
tor (Misonix) equipped with a titanium Microtip attachment. A micro-
scale version of the Trinder triglyceride assay (Sigma) was performed
on cell sonicates and read on anAmershamBiosciences BioTrakIImicro-
titer plate reader. Total triglyceride content was normalized to total
cellular protein assessed using a BCA protein assay (Pierce).
2.12. Particle degradation assays
Isolated particles or post nuclear supernatants were treated with
1% Tween-20, 1% Triton-X-100, or 100 units of Candida rugosa lipase
(all prepared in 10 mM TRIS, pH 7.4). Following a 1 h incubation par-
ticles were analyzed using NDGGE and immunoblotting as previously
described. To further validate lipase degradation assays, plasma sam-
ples were treated as above and analyzed using a modification of the
technique of Papadopoulos and Kintzios [54]. Briefly, plasma samples
were electrophoresed through 0.5% agarose gels cast and run in
50 mM TRIS pH 8.6. Gels were fixed by treating for 45 min with
2.5% TCA, rinsed in water for 20 min, dried on glass plates overnight,
and stained for 1 h in a freshly prepared saturated solution of oil red O
in 80% methanol.
3. Results
3.1. Perilipin 5 exists in two distinct cellular compartments
Previous studies have reported that perilipin 5 localizes to lipid
storage droplets [29–31]. However, several of these same studies
also found that a significant fraction of the protein was not bound
to conventional LDs, but rather, was associated with a poorly-defined
cytosolic pool. To further probe this observation, Chinese Hamster
Ovary fibroblasts (CHO-K1) were transfected with a carboxy-
terminal 3-xFLAG labeled perilipin 5 c-DNA construct (perilipin 5-
3X-FLAG). CHO cells do not express endogenous perilipin 5, but have
been successfully employed in ectopic expression studies by several
labs to elucidate multiple functions of PAT proteins [15,31,34,39].
Epitope-tagged perilipin 5 was found to localize to the perimeter
of lipid storage droplets (Fig. 1A and B, denoted by double arrows).
In the absence of exogenous fatty acids, CHO-K1 cells also formed nu-
merous small lipid droplets in the cytosol, as evidenced by coincident
neutral lipid staining (arrowheads, Fig. 1B). However, a significant
portion of the perilipin 5 staining did not colocalize with neutral
lipid, but instead was found on punctate structures distributed
throughout the cytosol (single arrows, Fig. 1B).
To confirm this observation, cells were disrupted and fractionated
using ultracentrifugation in a 0–30% sucrose gradient. The protein
composition of the gradient fractions was examined using immuno-
blotting, which revealed that the majority of perilipin 5 partitioned
with dense fractions at the bottom of the gradient (migrating with
natively expressed perilipin 3, lanes 5 and 6, Fig. 1C). In contrast,
the majority of perilipin 2 immunoreactivity was found in the most
buoyant fraction at the top of the gradient (lane 1, Fig. 1C). Some of
the perilipin 5 partitioned into the buoyant fraction, as would be
expected when in association with low-density LDs.
To determine if the non-buoyant fraction of perilipin 5 was
associated with other organelles, immunofluorescence microscopy was
employed. No colocalization was observed with antibodies directed
against LAMP-1 (lysosomes), LAMP-2 (lysosomes), EAA 1 (early endo-
somes), complex Va protein (mitochondria), or golgin 97 (Golgi) (data
not shown).
Immunofluoresence experiments were also conducted to test for
the presence of perilipin 2 (Fig. 1D). Perilipin 5 was observed on the
surface of structures presumed to be lipid storage droplets and colo-
calized with perilipin 2 on these structures. Perilipin 2 was not ob-
served in the cytosol or on the punctate perilipin 5 structures.
3.2. Perilipin 5 forms discrete structures in the cytosol
Due to the lack of colocalization with other structures and the
punctate nature of the perilipin 5 staining, we hypothesized that peri-
lipin 5 was organized into some type of unique macromolecular
structure. To resolve perilipin 5 from other organelles, sucrose gradi-
ents were extended from 0–30% to 0–60% (Fig. 2A). If perilipin 5
existed as a free protein in the cytosol, it would be expected to parti-
tion at the bottom of these gradients, rather than co-migrating with
marker proteins for other organelles. Dot blot analysis revealed that
perilipin 5 partitioned into two different density ranges: perilipin 5
bound to low density LDs was found in the least buoyant fraction
(b1.0 g/ml), and perilipin 5 while a second pool of perilipin 5 parti-
tioned in the 1.10 to 1.17 g/ml density range (lanes 6 and 7,
Fig. 2A). These fractions were less dense than those in which markers
for cytosol (GAPDH), endoplasmic reticulum (calreticulin) or mito-
chondria (mitochondrial complex IV) migrated (Fig. 2B).
Due to the discrete density range of the non-buoyant pool of perili-
pin 5 we hypothesized that this portion of perilipin 5 was bound either
to membrane bilayer-invested vesicles, small lipid-filled structures,
or both. Since perilipin 5 fails to colocalize with any of the common or-
ganelle markers we used, we hypothesized that at least a portionmight
associatewith unique, small, dense, lipidic structures. To further charac-
terize this pool of perilipin 5, NDGGE of sucrose gradient fractions
coupled with immunoblotting was employed. The least dense fractions
of the sucrose gradient contained particles too large to penetrate the gel
(Fig. 2C, leftmost lane); however, perilipin 5 in the higher density range
did migrate into the gel, with the majority found as a single discrete
band of approximately 575 kDa, consistent with structures having a
Stokes diameter of ~15 nm (Fig. 2C, asterisk).
3.3. Electron microscopy reveals distinct size of high-density perilipin
5-containing structures
In images obtained using fluorescent microscopy with high numer-
ical aperture objectives, the size of discrete, perilipin 5-containing
cytosolic structures was determined to be on the order of ~200 nm.
Equivalent measurements were obtained using sub-resolution fluores-
cence microspheres, indicating that the size of these perilipin 5-
labeled particles was possibly below the resolution limit of optical
microscopy. To independently verify the size of the particles we per-
formed TEM on immunoprecipitated material isolated from lysates
of CHO cells stably expressing perilipin 5-3XFLAG. The immuno-
precipitated particles were found to be of relatively uniform size with
a roughly circular appearance, and exhibited an average diameter of
16.7 nm and a median size of 12.5 nm (Fig. 3A–C). This was in close
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agreement with the predicted Stokes diameter of ~15 nm determined
using NDGGE. Quantitative analysis of these structures using manual
pixel counting further revealed an apparent periodicity to the sizes of
the particles, with minor peaks occurring at 35–40, 60–65, and
85–90 nm (Fig. 3D).
3.4. High-density perilipin 5-associated structures are devoid of perilipin 2
Co-immunoprecipitation was employed to determine which other
proteins might also reside on the particles identified using EM
(Fig. 4). Four different fractions from the sucrose gradient of perilipin
5-3x-FLAG expressing cells were analyzed: the least dense fraction
(1) and the more dense fractions (6 and 7, combined) of both oleic
acid treated and untreated cells. Each of these fractions was precipi-
tated with an anti-FLAG resin and subjected to immunoblotting
with the indicated antibodies. Perilipin 5-3x-FLAG was found in the
denser fractions of both gradients, but in the least dense fraction
only of oleic acid treated cells (Fig. 4A), validating the findings of im-
munoblots conducted on gradient fractions. Perilipin 2 was only
found in association with perilipin 5 on large, buoyant lipid droplets
and not on the dense structures, consistent with our immunofluores-
cent microscopy findings (Fig. 1D).
When native gradient gel electrophoresis was applied to material
immunoprecipitated from dense fractions of PLIN5-expressing CHO
cells, discrete bands of ~575 kDa were detected in the resulting im-
munoblots (Fig. 4C). These data suggest that the particles observed
by TEM (above) had retained their integrity throughout the immuno-
precipitation procedure.
3.5. Expression of perilipin 5 in CHO cells results in altered lipid storage
and lipid droplet size
Other groups have found that ectopically expressed perilipin 5
resulted in increased lipid storage [30,31]. To confirm that ectopic
D
Peri 5                   Peri 2                 Merge 
A
B C
Fig. 1. Perilipin 5 localizes to biochemically distinct intracellular pools. A. Confocal images of a representative CHO cell stably expressing the perilipin 5-3X-FLAG construct (green).
The perilipin 5-3X-FLAG protein was detected using an anti-FLAG antibody (green). Neutral lipids were stained through incorporation of BODIPY 558/568 C12 (red), and nuclei
were stained with DAPI (blue). Scale bar=10 μm. B. Inset from merged image (right panel in A). Under basal growth conditions, perilipin 5-3X-FLAG localized to both LDs (double
arrows) as well as smaller punctate structures in the cytosol. Of the latter, some were associated with neutral lipid staining (arrowheads), while others were apparently devoid of
BODIPY 558/568 C12 labeling (arrows). C. Perilipin 5-3X-FLAG-expressing CHO cell lysates prepared following incubation in lipid-loading medium, were subjected to ultracentri-
fugation using conventional discontinuous sucrose density gradients (0–30%). Immunoblots were prepared using aliquots of equal volume fractions of the gradients, arranged from
low (L) to high (H) density, and probed with anti-FLAG, anti-perilipin 2 (ADRP), and anti-perilipin 3 (TIP47) antibodies. Whereas the majority of perilipin 2 and perilipin 3 parti-
tioned into either low or high-density fractions, respectively, perilipin 5-3X-FLAG was recovered in fractions at both extremes of the density gradient. D. Confocal images of a rep-
resentative CHO cell stably expressing the perilipin 5-3X-FLAG construct (green) and stained with an anti-perilipin 2 antibody (red). Merged images are shown in yellow. Both
perilipin 5 and perilipin 2 localize to lipid storage droplets but only perilipin 5 is found on punctate structures.
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expression of perilipin 5 in CHO was not resulting in anomalous lipid
storage, we quantified TAG levels in these cells. Expression of the
perilipin 5-3x-FLAG fusion protein resulted in a 70% increase in cellu-
lar TAG levels over control levels (Fig. 5). This increase was also
observed when cells were treated with oleic acid to increase lipid
accumulation.
Expression of perilipin 5-3x-FLAG in CHO cells resulted in an
increase in LD size (Fig. 6A and B). What was intriguing, however,
was the apparent change in LD size distribution. While expression
of perilipin 5 only increased neutral lipid stores in these cells by 1.7
fold, the diameter of the largest LD observed in each perilipin 5-
expressing cells was increased by over 2.5 fold (Fig. 6B). This increase
in the diameter of the largest droplets was associated with a shift in
the size of the smaller droplets (Fig. 6B). To confirm that this effect
was not an artifact of conjugation with the FLAG peptide, the experi-
ment was repeated using CHO cells transfected with a native perilipin
5 construct. No difference was noted in either the diameter of the
largest droplet in each cell or in the distribution of the droplet size
(Fig. 6C and D). In this instance our data suggest that perilipin 5
participates in the maintenance of the organization and structure
of intracellular LDs.
3.6. Characterization of perilipin 5 in mouse heart and liver validates
what is observed in cultured cell models
To ensure that the observed results in CHO were not a result of
overexpression or of the model system used, select experiments
were repeated using heart and liver from fasted mice. These tissues
and conditions were chosen based on previous reports indicating
perilipin 5 expression would be elevated in these organs and meta-
bolic states.
Lysates of heart and liver tissue were subjected to sucrose gradient
ultracentrifugation and NDGGE (Fig. 7A and B). Native perilipin 5 in
either heart (A) or liver (B) was found to migrate in the sucrose gra-
dient in a similar density range (d=1.10–1.17 g/cm3) to what was
found using CHO cells expressing FLAG tagged perilipin 5. When
sucrose gradient fractions were subjected to NDGGE and immunoblot
analysis with an anti-perilipin 5 antibody, perilipin 5 was found tomi-
grate in a relatively sharp band with a molecular weight of ~575 kDa
and diameter of approximately 15 nm, again, indistinguishable from
what was observed using the CHO model system. Differences in size
or density were not observed between heart and liver samples.
Collectively, these data indicate that our observations and predic-
tions made using the transfected CHO model are an accurate reflec-
tion of the biology occurring in mouse heart and liver.
3.7. The high density pool of perilipin 5 interacts with perilipin 3 and
contains a lipid core
To determine the content of the core of the perilipin-5 particles,
we characterized particles isolated from sucrose gradients of liver
samples described in the previous experiment. These particles were
subjected to one of four treatments: 100 units of C. rugosa lipase,
1% Tween-20, 1% Triton-X-100, or a control incubation. Following
treatment, the samples were analyzed using NDGGE and immuno-
blotting as previously described.
Treatment of the particles with lipase ablated the band migrating
at 575 kDa. Similarly, treatment with Tween-20 had a mild effect, de-
creasing the intensity of the 575 kDa band and causing a shift of stain-
ing to smaller sized particles. Triton, a milder detergent than Tween,
had at best a weak effect on the band. Based on these observations
we conclude that the particle has a core of neutral lipid. In the pres-
ence of lipase the core is degraded and the particle loses its integrity.
Low concentrations of Tween 20 begin to affect the particle the same
way as the lipase, but Triton-X-100 is unable to solubilize the particle
under these conditions.
To confirm that the lipase treatment would degrade a particle
with a triacylglycerol core, plasma samples were treated with deter-
gent or lipase as described and subjected to agarose electrophoresis
and oil red o staining. In untreated samples bands were evident for
VLDL/chylomicra, LDL, and HDL. In samples treated with Tween-20
the particles collapsed into a single band which entered the gel with
difficulty. In lipase treated samples the triacylglycerol rich bands
(VLDL and chylomicra) were ablated but the cholesteryl ester rich
bands (LDL and HDL) remained further confirming that lipase treat-
ment was able to degrade triacylglycerol rich particles.
To determine if perilipin 3 resides on the same complex, blots were
probed with an anti-perilipin-3 antibody. Bands were observed at
575 kDa, indicating that if the two perilipin proteins were not cohabi-
tating the same droplet, they were at the least on droplets of similar
size. In addition to the 575 kDa band we also observed a new band
at 300 kDa. This band did not seem to be effected as strongly by the
lipase or Tween treatments.
C
B
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GAPDH
Calreticulin
Mito IV
Fig. 2. A portion of perilipin 5 is associated with high-density structures of a discrete
size. A. Perilipin 5-FLAG-expressing CHO cell lysates were subjected to ultracentrifuga-
tion using extended discontinuous sucrose density gradients (0–60%). Dot blots were
prepared using aliquots of equal volume fractions of the gradients, arranged from
low (L) to high (H) density, and probed with anti-FLAG, anti-perilipin 2 (ADRP), and
anti-perilipin 3 (TIP47) antibodies. When the gradients were extended over a wider
density range, perilipin 5 was found to partition into both low-density (buoyant) frac-
tions (lane 1) as well as fractions of higher density (lanes 6–7), but was essentially ab-
sent in the fractions of highest density (lanes 9–11). B. Marker proteins for cytosol
(NADPH) ER (calreticulin) and mitochondria (mito complex IV) are shown. C. Non-
denaturing gradient gel electrophoresis was performed using sucrose gradient frac-
tions prepared as described in A. Immunoblots were probed with anti-FLAG antibodies.
Immunoreactive material that partitioned into the denser fractions of the gradient also
migrated into the gel under non-denaturing conditions, revealing an approximate size
of 575 kDa (marked by the asterisk, *). A small amount of immunoreactivity was found
migrating near the predicted size of perilipin 5 (double asterisk, **). Please note that
each panel contains representative data from different experiments.
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To further probe the interactions of perilipins 5 and 3, CHO cells
were cotransfected with cDNA constructs coding for the perilipin 5-
3xFLAG fusion protein and a perilipin-3-EGFP fusion protein. Cells
were cultured for 16–20 h post transfection and post nuclear super-
natants were prepared and treated as previously described. To con-
firm that the banding pattern seen was the same for both proteins,
blots were first probed with an anti-GFP antibody, then stripped
and reprobed with an anti-FLAG antibody (Fig. 8B). As was seen in
liver samples, a lipase sensitive band was seen that was detectable
with both anti-FLAG antibodies (indicating the presence of the
perilipin-5-3xFLAG fusion protein) as well as anti-GFP antibodies (in-
dicating the presence of the perilipin-3-EGFP fusion protein). Howev-
er, it should be noted that this band was observed at 300 kDa and not
at the larger 575 kDa band seen in our other studies. A minor band of
575 kDa was observed in several samples.
To confirm that perilipins 3 and 5 were indeed residing on
the same particle, samples of the transient transfections were
immunoprecipitated using an anti-FLAG resin (Fig. 8C). The perilipin
3-GFP fusion protein was detected in the precipitate by probing
with either anti-perilipin-3 or anti-GFP antibodies (data not shown)
indicating that in these samples, some fraction of perilipin 3 was
found on the same particle as perilipin 5.
4. Discussion
Perilipin 5 is the most recently identified member of the PAT pro-
tein family. Several studies on this protein have shown that it resides
in multiple intracellular locations: ER, LDs, and an uncharacterized
cytosolic pool [29–31,33]. This work characterizes the cytosolic pool
and offers that rather than existing as free protein in the cytosol, peri-
lipin 5 is associated with discrete, high density lipid droplet (HDLD)
particles with a lower size limit of approximately 15 nm in diameter.
Furthermore, based on the size distribution of LDs, we speculate that
this protein is involved in the trafficking of lipid from distal regions of
the cell to central LDs.
Of the PAT proteins, perilipin 1A is the best characterized, but it is
also one of the most divergent in amino acid sequence and likely has
the most specified function. While perilipin 1A is not found in the cy-
tosol under basal conditions, prolonged stimulation by PKA can cause
LDs to fragment into thousands of “micro LDs”. It is unclear if they
Fig. 3. Amajority of high-density perilipin 5-containing structures have a size of less than 20 nm. Transmission electronmicroscopywas performed onmaterial immunoprecipitated from
the post-nuclear supernatant isolated from perilipin 5-3X-FLAG-expressing CHO cells grown under basal conditions. A–C Representative images of negative stained immunoprecipitated
fractions. Scale bars=100 nm. D. Histogram showing the size distribution of 500 particles from randomly chosen, non-overlappingmicroscopic fields, as determined usingmorphometric
analysis.
Fig. 4. Co-immunoprecipitation of perilipin 5 coated particles confirms a lack of perili-
pin 2/ADRP in high-density structures. In A–C, cells were either treated with oleic acid
(+OA) or basal growth conditions (−OA). Sucrose gradient (0–60%) ultracentrifuga-
tion was performed and fractions 1 (low density) or 6 and 7 (high density) were
immunoprecipitated with anti-FLAG beads. The eluted material was subjected to
SDS-PAGE and either prepared for immunoblot analysis (A, B), or developed using sil-
ver staining, as noted. D. Immunoprecipitated particles from CHO cells were eluted
with FLAG peptide and analyzed by non-denaturing gradient gel electrophoresis fol-
lowed by immunoblotting and detection using anti-FLAG antibodies. No shift in the
size of these ~575 kDa particles was observed following immunoprecipitation.
Fig. 5. CHO fibroblasts expressing perilipin 5 store more TAG than control cells. CHO
cells expressing the perilipin-5 3-X-FLAG fusion protein or transfected with a control
plasmid were assayed for cellular TAG in the presence or absence of exogenous oleic
acid (OA) treatment for 24 h (n=6). TAG data were normalized to total protein con-
centration (mean±SEM). Relative to control cells, perilipin 5 expressors stored 0.7-
fold more TAG under basal and lipid-loaded conditions.
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have a lower size limit, and if so, what other proteins may reside on
those structures. It has been speculated that this increase in surface
area by fragmentation grants lipases greater access to the TAG con-
tents of the LD under conditions of prolonged lipolysis [46].
Immunofluorescence microscopy on the punctate HDLDs failed in
many instances to costain for neutral lipid when stained with BODIPY
C12. This may be due to the small amount of lipid we propose to be
contained in these particles or the dye may not be sensitive enough
to stain these structures.
Others have proposed that the e-PATs, specifically perilipins 3 and
4, act to coat developing lipid droplets when the cell is presented with
a fatty acid challenge [26–28,47]. Our data support this conclusion,
and also suggest that perilipin 5 may perform an analogous, although
opposite function to the dispersion phenomenon observed with peri-
lipin 1A. We speculate that, without excess fatty acids for the cell to
store, perilipin 5 resides in the cytosol until the cell encounters a
fatty acid challenge. When the cell encounters a fatty acid challenge,
the excess fatty acids that enter the cell, are packaged into small
(10–20 nm diameter) TAG particles coated by perilipins 3 and 5,
and then trafficked to the larger LD. There, droplets are coated by
perilipins 2, the terminal c-PAT protein commonly found in muscle
and liver cells, and perilipin 5.
While perilipin 3 has clearly been demonstrated to be a lipid
droplet protein, other functions of perilipin 3 are a subject of contro-
versy in the literature. Previous studies have shown perilipin 3 to be
a mannose-6-phosphate receptor trafficking protein, interacting
with Rab-9 and Rho BTB3, while other studies have cast doubt on
some of these ascribed functions and interaction partners [22–24,
47–49]. Many of these same studies have also shown that perilipin
3 is found in the cytosol as well as other locations in the cell (plasma
membrane or Golgi as well as LDs). A recent study has colocalized
perilipin 3 with tubular ER [33]. This same study found that loading
cells with a soluble diacylglycerol drives all three e-PATs (perilipins
3, 4, and 5) to the ER from the cytosol. Sequence analysis reveals that
the closest relative to perilipin 5 is perilipin 3, and our findings fit
quite well with what has been observed regarding e-PATs by Skinner
et al. The nature of the cytosolic pool of any of the e-PATs has not
been explored. We propose that under normal conditions, at least
a portion of perilipin 5 resides on small dense particles within the
cytosol. When cells are treated with oleic acid to promote lipid depo-
sition, perilipin 5 shifts from this dense pool to the lipid storage
droplet in our system, while in that of Skinner et al. it shifts from
the cytosol to ER (presumably before transitioning to a mature peri-
lipin 2 coated LD). While we have not observed co-localization of
perilipin 5 with ER, these differences may be explained by the differ-
ences in model system or experimental treatment. It also may be
that differences in these studies indicate that the cell responds dif-
ferently to different lipid challenges (oleic acid vs. soluble diacylgly-
cerols). Based on our data, it is quite plausible that perilipin 5 serves
as an intermediate between perilipins 3 and 2, binding to small,
nascent pools of lipid, interacting with trafficking proteins, and
effecting movement of lipids to mature LDs.
Fig. 6. Expression of perilipin 5 mediates a remodeling of lipid droplets. A. Lowmagnification micrographs (top row) and images of representative cells (bottom row) of lipid-loaded
control CHO cells (transfected with control plasmid), and CHO cells expressing perilipin 5-3X-FLAG. Lipid droplets were stained through incorporation of BODIPY 558/568 C12 and
appear dark on a light background. Note the increased size of the lipid droplets in the cells expressing perilipin 5-3X-FLAG (arrow). Scale bars=10 μm. B. The total number and size
of LDs in CHO cells stably transfected with control plasmid or perilipin 5-3X-FLAG was determined using quantitative morphometric analysis. Following lipid-loading for 24 h, a
significant shift in the percentage of larger LDs was observed with expression of perilipin 5 (inset). C and D. The experiments shown in panels A and B were repeated using a plasmid
in which the FLAG epitope was removed (perilipin 5). C. Lipid-loaded CHO cells stably transfected with either control plasmid, or with perilipin 5-3X-FLAG or perilipin 5 expression
plasmids, were fixed and immunolabeled with anti-perilipin 5 antibodies (green). Neutral lipids were stained through incorporation of BODIPY 558/568 C12 (red), and nuclei were
stained with DAPI (blue). Scale bars=10 μm. D. Scatterplots of the largest LD diameter per cell in the experiment described in C, as determined using morphometric analysis. There
was no discernable effect of the FLAG epitope tag on the accumulation of large lipid droplets.
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Our data indicate that perilipin 3 also resides on a discrete HDLD
structure with defined lipid and protein components. Perilipin 3 and
perilipin 5 (but not perilipin 2) were found to migrate at a similar
density in sucrose gradient ultracentrifugation and have a similar
banding pattern in NDGGE. Likewise, using an anti-FLAG resin we
were able to immunoprecipitate EGFP labeled perilipin 3 in a cotrans-
fected CHO model system.
We currently have no good explanation as to why HDLD particles in
cells expressing ectopic perilipin 3-EGFP are smaller in size. Thismay be
due to expression levels or a previously unknown complication of the
EGFP tag. However, we speculate that this may provide a tool to further
characterize perilipin protein function in future studies. It may be that
when perilipin 3 is overexpressed it sequesters perilipin 5 in 300 kDa
particles preventing its maturation into larger particles (i.e. 575 kDa
particles).
We did not observe significant colocalization of perilipin 3 and
perilipin 5 using immunofluorescence; however, that may be due to
sensitivity issues related to the small sizes of the particles in question.
The other data presented clearly indicate that perilipins 3 and 5 spend
some time either directly interacting or bound to the same particle.
It should be noted that the cotransfection studies shown in Fig. 8B
and C were conducted with a 3xFLAG tagged perilipin 5 protein and
an EGFP tagged perilipin 3 protein. Given the nature of these epitope
tags it is possible that the tag is influencing the localization or parti-
tioning of the proteins, however, the comigration of perilipin 5 and
perilipin 3 in sucrose density gradients and gradient gels are sugges-
tive that these proteins occupy similar, if not the same pool. Immuno-
fluorescence microscopy of doubly labeled cells failed to show
significant colocalization of perilipin 3-EGFP and perilipin 5-3xFLAG,
however, the epitope tagged perilipin 3 exhibited reticular staining
in those experiments. Using liver lysates we were unable to cleanly
coimmunoprecipitate perilipin 5 with an anti perilipin 3 antibody or
perilipin 3 with an anti perilipin 5 antibody.
Fig. 7. Native murine perilipin 5 also forms high-density structures of a discrete size.
Heart (A) and liver (B) samples from fasted 8–10 male C57/Bl6 mice were subjected
to ultracentrifugation using extended discontinuous sucrose density gradients
(0–60%) and examined using non-denaturing gradient gel electrophoresis as described
in Fig. 2. Immunoblots were probed with anti-perilipin 5 antibodies. The approximate
density at which staining was observed (d=1.10–1.17 g/ml) and size of the bands
(~575 kDa) was indistinguishable from those observed in the CHO model system.
n=5 animals, representative blots shown.
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Fig. 8. The small, dense perilipin 5 structures are also coated with perilipin 3 and have a
lipid core. A. Mouse liver samples from fraction 7 of gradients shown in Fig. 7 were
treated with 100 units of Candida rugosa lipase, 1% Tween-20, or 1% Triton-X-100 for
1 h and subjected to non-denaturing gradient gel electrophoresis and immunoblotting
as previously described. The panel on the left was probed with an anti-perilipin 5 an-
tibody while the panel on the right was probed with an anti-perilipin 3 antibody.
Both sets of samples had banding apparent at 575 kDa. An additional band was seen
migrating at approximately 300 kDa in blots probed with anti-perilipin 3 antibody
(but not perilipin 5). Treatment with lipase ablated the perilipin 5 coated particles
seen migrating at 575 kDa. Treatment with Tween-20 caused a shift in the 575 kDa
band, however no change was seen in the Triton treated samples (n=4, representative
blots shown). B. CHO cells were transiently transfected with cDNA fusion constructs
coding for both perilipin-5-3xFLAG and perilipin-3-EGFP. Post nuclear supernatants
were prepared and experiments were performed as previously described. Blots were
first detected using anti-GFP antibody, then stripped and reprobed with anti-FLAG an-
tibody. Under these conditions the predominant band was observed at 300 kDa with a
minor band seen at 575. Both proteins migrated to the same region of the gel. Treat-
ment with lipase eliminated these bands (n=4, representative blots shown). C. To de-
termine if perilipin 3 was found on the same particle as perilipin 5, post nuclear
supernatants were immunoprecipitated with an anti-FLAG antibody as previously de-
scribed. The perilipin 3-GFP fusion protein was detected in the precipitate by probing
with either anti-perilipin-3 or anti-GFP (data not shown). D. To confirm that lipase
treatment would degrade the core of triacylglycerol rich particles, plasma samples
were analyzed following treatment with tween-20 or lipase and analyzed using aga-
rose gel electrophoresis as described in Methods. Treatment of samples with lipase de-
graded triacylglycerol rich lipoproteins but not cholesteryl ester rich lipoproteins.
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Recent reports by Bulankina et al. propose a hypothetical arrange-
ment of perilipin 3 on a discoidal structure analogous to nascent
HDL-3 [47] in which the amphipathic helical regions of perilipin 3
are partially wrapped in a disk of phospholipids. Perilipins 3 and 5 are
conserved through this region in the amino terminus. Based on our
electron microscopy data, we propose a similar interaction of these
amphipathic helical regions of perilipin 5 with a spherical particle.
4.1. Changes in droplet size reflect a role for perilipin 5
We propose that perilipin 5 functions as part of the cellular ma-
chinery that transports lipid from distal regions of the cell to mature
LDs. In support of this hypothesis, we have observed that an overall
change in the distribution of LDs accompanies ectopic perilipin 5 ex-
pression, with larger and fewer LDs in lipid-loaded CHO cells expres-
sing perilipin 5 than controls. While the argument can be made that
this is an effect of ectopic expression of a PAT protein, ectopic expres-
sion of perilipin 1A and a series of mutant perilipins all target to LDs
and impact lipid storage without affecting LD size (total mass of
lipid is increased without a change in the diameter of LDs compared
to control cells), indicating an increase in the total number of droplets
[34]. Likewise, we have not observed these effects when perilipin 2 is
overexpressed in either CHO or C2C12 cells (B. Colopy and JT Tansey,
unpublished data).
4.2. A proposed structure for high-density perilipin5-containing particles
Our observations indicate that perilipin 5 does not exist as a free
protein in the cytosol. Based on the diameter and the density of the
observed particles, we propose that at least a portion of the cytosolic
fraction of perilipin 5 resides on a lipoprotein-like structure in which
a neutral lipid core is surrounded by a coating of phospholipids and
protein.
We have not excluded the possibility that these small particles
have an aqueous core surrounded by a phospholipid bilayer (effec-
tively a small unilamellar vesicle); however, we find this hypothesis
lacking in several regards. First, electron microscopy failed to show
a phospholipid bilayer on immunoprecipitated particles. Secondly,
while density calculations cannot rule out the possibility of an aque-
ous core, the mass percent protein in these particles would be less
than 25%, a low value compared to other biological structures of this
size. Finally, the radius of curvature for a particle with a diameter of
15 nm creates unfavorable strains and molecular packing for a bilayer
system [40]. Recent studies suggest that this may be independent of
the type of lipid forming the bilayer [41]. While synthetic small unila-
mellar vesicles can be produced in the laboratory with diameters as
small as 25 nm (significantly larger than our particles), the synthesis
of these particles requires extrusion, organic solvents, strong deter-
gents, non-naturally occurring lipids or high energy sonication
[42,43]. The nearest sized biological structure referenced in the liter-
ature are small caveolae (20–50 nm at the low end of their size range)
[44]. Mathematical modeling of organelle formation also indicates the
expected minimum size of bilayer structure is larger than our 15 nm
particles [45]. The perilipin 5 containing particles we have identified
have a similar size and density to high-density lipoprotein particles
and as such, we hypothesize that they have a similar structure.
4.3. Lipoproteins: an existing paradigm
Several groups have suggested that the PAT proteins may play
analogous roles to apolipoproteins found on plasma lipoproteins
[7,20,25–28]. Plasma apolipoproteins act as ligands for receptors, co-
factors for lipases, and amphipathic coatings for the hydrophobic core
of the lipoprotein. Through these diverse roles apolipoproteins regu-
late the trafficking and metabolism of the neutral lipid contents of the
lipoprotein. PAT proteins exhibit many analogous properties. Perilipin
1A acts as a regulator of both HSL and ATGL [17,34,39,50–52]. Both
perilipins 1A and 5 interact with CGI-58 [15,16,32,53]. Perilipin 2
and 3 have been shown to interact with cellular machinery involved
in trafficking and perilipin 2 sequesters proteins involved in vesicular
or LD fusion [3,35]. All PAT proteins coat LDs and several have been
shown to play important regulatory roles in the metabolism of the
neutral lipid contents.
Several significant differences separate these two analogous sys-
tems. Perilipin 1A appears to be regulated via phosphorylation of
PKA sites, but it is the only member of the family recognized to be
regulated by this mechanism. In addition, PATs are intracellularly
localized while lipoproteins are extracellularly localized. Finally, LDs
can reach sizes that are orders of magnitude larger than the largest
lipoprotein. We sought to explore the possibility that PATs may be
acting as a sort of intracellular lipoprotein by characterizing their
structure, composition, and functions. If structures analogous to plas-
ma lipoproteins were found in cells, it could provide an analogous
paradigm for the study of lipid traffic and storage in the organism.
Here, we describe the cytosolic compartment of perilipin 5 and pro-
pose that it is similar in both size and density to plasma lipoproteins.
We do not propose that these small structures are the only perilipin 5
containing structures in the cytosol, but that they are clearly one of
the most prevalent in the absence of exogenous lipid. Likewise, our
data reveal that perilipin 5 is not found free in the cytosol, but rather
is always found bound to some lipidic structure. Further identification
of the components of this complex will be necessary to decipher the
function and mechanism of perilipin 5 in lipid metabolism.
5. Conclusions
Questions have been raised as to why a LD protein has any resi-
dence time in the cytosol. These studies now reveal that, at least in
the instance of perilipins 3 and 5, a portion of the cytosolic pool con-
taining these proteins is bound to a lipidic structure. Perilipin 2 has
been shown to sequester proteins involved in vesicular fusion, and
we speculate that the cytosolic pool of perilipin 5 may act in a similar
fashion. We propose a model wherein, in the absence of excess fatty
acids, perilipin 5 resides in cytosolic HDLDs awaiting a fatty acid chal-
lenge. When lipid levels rise, cytosolic perilipin 5 coats these nascent
LDs until they can be stabilized by a c-PAT (perilipin 1 or 2).
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